Výsledky vyhledávání - "Slađana Mićić"

Significance of Beta-Blocker in Patients with Hypertensive Left Ventricular Hypertrophy and Myocardial Ischemia

Autor: Milovan Stojanovic, Goran Koracevic, Slađana Mićić, Nenad Bozinovic, Dragan Simic, Dragan Lović, Nebojsa Krstic, Ružica Janković Tomašević

Publikováno v: Current Vascular Pharmacology. 21:81-90

Background: Arterial Hypertension (HTN) is a key risk factor for left ventricular hypertrophy (LVH) and a cause of ischemic heart disease (IHD). The association between myocardial ischemia and HTN LVH is strong because myocardial ischemia can occur i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7f2f67d3db8f3b2c1bd53acaf9b858c2
https://doi.org/10.2174/1570161121666230201141215

Zobrazit plný text záznamu

Contraindications Differ Widely Among Beta Blockers and Ought to be Cited for an Individual Drug, Not for the Entire Class

Autor: Milovan Stojanovic, Tomislav Kostić, Slađana Mićić, Dragan Lovic, Dimitrije Pavlović, Marija Zdravkovic, Maja Koracevic, Goran Koracevic

Publikováno v: Current pharmaceutical design. 27(40)

Beta blockers (BBs) have important side effects that contribute to low adherence and persistence. Therefore, the optimal choice of BB is an important mode to prevent BB’s side effects, leading to an increase in compliance, which can improve the out

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::372d34765c7f567c170d706d3e750f03
https://pubmed.ncbi.nlm.nih.gov/34279195

Zobrazit plný text záznamu

Single prognostic cut-off value for admission glycemia in acute myocardial infarction has been used although high-risk stems from hyperglycemia as well as from hypoglycemia (a narrative review)

Autor: Goran Koracevic, Slađana Mićić, Miloje Tomasevic, Milovan Stojanovic, Tomislav Kostić, Irena Janković, Maja Koracevic

Publikováno v: Primary care diabetes. 14(6)

All original articles and meta-analysis use the single cut-off value to distinguish high-risk hyperglycemic from other acute myocardial infarction (AMI) patients. The mortality rate is 3.9 times higher in non-diabetic AMI patients with admission glyc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3246ac7eebbe14eba8b08cacbb796097
https://pubmed.ncbi.nlm.nih.gov/32988774

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání